Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
American Sales Company, Inc. v. Novo Nordisk A/S et al
Case Number:
2:10-cv-12141
Court:
Nature of Suit:
Judge:
Firms
- Berger Montague
- Cafferty Clobes
- Cohen Milstein
- Faruqi & Faruqi
- Gibson Dunn
- Hagens Berman
- Honigman LLP
- Sullivan & Cromwell
- Taus Cebulash
Companies
Sectors & Industries:
-
November 18, 2014
Novo Nordisk Pays $19M To Settle Prandin Antitrust Action
Novo Nordisk A/S has agreed to pay $19 million to settle a putative class action in Michigan federal court accusing it of attempting to monopolize the market for popular diabetes treatment Prandin by pursuing sham infringement litigation against generic-drug makers.
-
June 01, 2010
Novo Nordisk Hit With Antitrust Action Over Prandin
Novo Nordisk A/S has been slapped with a putative class action that accuses it of attempting to monopolize the market for popular diabetes treatment Prandin by pursuing sham infringement litigation against generic-drug makers.